4//SEC Filing
Hassard James 4
Accession 0001209191-22-017938
CIK 0001658247other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:51 PM ET
Size
5.6 KB
Accession
0001209191-22-017938
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-10+160,000→ 160,000 totalExercise: $19.73Exp: 2032-03-09→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as follows: 25% of the shares subject to the option vest on February 28, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001799357
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:51 PM ET
- Size
- 5.6 KB